Growth N V Biotech insider trades

Open-market stock purchases and sales by Growth N V Biotech, 10% Owner at Black Diamond Therapeutics, Inc, from SEC Form 4 filings since Nov 18, 2011.

Track record: 15% of 20 scored buys are up 5% or more since purchase, averaging -41%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • BDTX Black Diamond Therapeutics, Inc: 15 buys, 6 sales, last Mar 19, 2025
  • EPIX ESSA Pharma Inc: 6 buys, 3 sales, last Nov 1, 2024
  • RDUS Radius Health, Inc: 55 buys, last Nov 6, 2019
  • NONE Radius Health, Inc: 6 buys, last Feb 19, 2014

Get free alerts when Growth N V Biotech files a new trade →